Close

Leap Therapeutics Announces Encouraging Data from TRX518 Phase 1 in Immunosuppressive Cell Reduction (MCUR)

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 4/23/2024

1. TSLA
2. GM
3. SPY
4. SPOT
5. SHW
6. AMZN
7. AAPL
8. NVDA
9. MTTR
10. MINN


Go back to Leap Therapeutics Announces Encouraging Data from TRX518 Phase 1 in Immunosuppressive Cell Reduction (MCUR)
(NASDAQ: MCUR) Delayed: 1.51 --0 (-0%)
Previous Close $1.51    52 Week High $3.20 
Open $32.00    52 Week Low $0.75 
Day High $1.51    P/E N/A 
Day Low $1.51    EPS $0.00 
Volume 311,220